Biotechnology News

Mon, 2015-11-09 15:00

SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., today announced the presentation of nonclinical data demonstrating synergy between the CDK9 inhibitor, alvocidib, and a number of bromo and extra terminal (BET) protein inhibitors in...

Mon, 2015-11-09 14:01

SAN FRANCISCO--(BUSINESS WIRE)--Chondroitin sulfate is more efficient than anti-inflammatory drugs for delaying the progression of knee osteoarthritis. This is the main conclusion of a new study presented today at the ACR congress.

Mon, 2015-11-09 13:00

SAN FRANCISCO--(BUSINESS WIRE)--At the ACR Annual Meeting, Samumed unveiled groundbreaking pre‐clinical and clinical research that demonstrated successful modulation of the Wnt pathway for potential cartilage regeneration.

Mon, 2015-11-09 12:01

SALT LAKE CITY--(BUSINESS WIRE)--Tolero Pharmaceuticals, Inc., a late-stage pharmaceutical company developing treatments for serious hematological diseases, today announced that it has entered into an exclusive license to use Eutropics PraediCare...

Mon, 2015-11-09 12:01

INGELHEIM, Germany & INDIANAPOLIS, US--(BUSINESS WIRE)--New sub-analysis data presented today show the reduction in risk for hospitalisation for heart failure or cardiovascular (CV) death with Jardiance®, compared with placebo when added to...

Mon, 2015-11-09 12:01

BOSTON--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell will be one of 30 companies to present their latest innovations at CES Unveiled New York on November 10. CES Unveiled is produced by the Consumer Electronics...

Mon, 2015-11-09 12:01

WELLESLEY, Mass.--(BUSINESS WIRE)--Harvard Pilgrim Health Care and Amgen Inc., maker of the new LDL cholesterol lowering drug Repatha, have negotiated an agreement that will help to slow the growth of escalating health care costs.

Mon, 2015-11-09 12:01

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, Inc. continues its support of the Advanced Concepts in Electrophysiology (ACE), an educational program for electrophysiologists and device-oriented cardiologists, with the largest gathering this year...

Mon, 2015-11-09 11:00

CLEVELAND--(BUSINESS WIRE)--Hitachi Medical Systems America, Inc., a leading provider of diagnostic imaging equipment announced FDA clearance to market two new models within its Scenaria Platform, the new Scenaria SE 64 and SE 128. The Scenaria...

Mon, 2015-11-09 11:00

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics, an immuno-oncology company dedicated to the development of its tumor-angiogenesis targeting immune therapy, ValloVax™, announced today the appointment of Argyrios Theofilopoulos, MD of The Scripps...

Mon, 2015-11-09 11:00

ST. MARYS, W. Va.--(BUSINESS WIRE)--ProtoKinetix Completes Private Placement

Mon, 2015-11-09 10:01

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) and the COPD Foundation launched a new video series, Reel COPD, to share the first-hand stories of patients and their caregivers as they cope with a chronic,...

Mon, 2015-11-09 10:01

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that data from two drug candidates in its pipeline, GMI-1271 and GMI-1359, will be featured during one oral presentation and three poster sessions at the 57th...

Mon, 2015-11-09 10:01

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Settles All Litigation with Former CEO Pandolfino

Mon, 2015-11-09 10:01

ALBANY, N.Y.--(BUSINESS WIRE)--Lyophilization Equipment and Services Market to Expand at a CAGR of 8.5% between 2014 and 2020 Owing to Increase in Injectables for Diseases

Mon, 2015-11-09 10:01

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Operating Officer, will participate in a fireside chat at the Credit Suisse 24th Annual Healthcare...

Mon, 2015-11-09 10:01

NEW YORK--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has prevailed in defending a patent lawsuit filed by Datatrak International (...

Mon, 2015-11-09 10:01

ST. PAUL, Minn.--(BUSINESS WIRE)--Prospective data from study shows after 31 months of follow-up, heart failure patients managed with the CardioMEMS HF System had a 48 percent reduction in heart failure hospitalizations.

Mon, 2015-11-09 10:01

MELBOURNE, Australia--(BUSINESS WIRE)--Prana Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement

Mon, 2015-11-09 10:01

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation status to SD-809 (deutetrabenazine) for the...

Mon, 2015-11-09 10:01

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT and TASE:BTX) today reported financial results for the third quarter ended September 30, 2015 and provided an update on its recent accomplishments. “During the third quarter, BioTime and...

Mon, 2015-11-09 09:00

NEW YORK--(BUSINESS WIRE)--Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B virus (HBV) and chronic HBV and hepatitis delta virus (HDV) co-infection, announces allowance by the...

Mon, 2015-11-09 09:00

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announced positive subanalysis data of the Phase III lesinurad studies (CLEAR1, CLEAR2 and CRYSTAL) for the treatment of hyperuricemia associated with gout, in combination with a xanthine...

Mon, 2015-11-09 09:00

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group Announces Third Quarter 2015 Financial Results And Conference Call to Provide Business Update

Mon, 2015-11-09 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics today announced new data demonstrating the ability of its platform to more precisely determine tumor-specific gene changes in response to immunotherapy treatment.

Mon, 2015-11-09 09:00

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced company highlights and financial results for the third quarter ended September 30, 2015. “Since the beginning of the third...

Mon, 2015-11-09 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics today announced new data demonstrating the ability of its plasma-based liquid biopsy panel for solid tumors to detect EGFR mutations in patients with NSCLC.

Mon, 2015-11-09 09:00

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and nine months ended September 30, 2015....

Mon, 2015-11-09 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Warp Drive Bio Announces Formation of Board of World-Leading Oncology Experts to Focus on Company’s RAS Program

Mon, 2015-11-09 09:00

BOSTON--(BUSINESS WIRE)--PAREXEL International Corporation (NASDAQ: PRXL), today announced expanded evidence-based services for biopharmaceutical products via PAREXEL® Access.

Mon, 2015-11-09 09:00

BOSTON--(BUSINESS WIRE)--Vision Medicines announces exclusive worldwide license from Case Western Reserve University for drug candidate for Stargardt disease. Stargardt leads to legal blindness.

Mon, 2015-11-09 09:00

FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, today introduced the CESI 8000 Plus, their next generation CESI-MS platform,

Mon, 2015-11-09 09:00

BOSTON--(BUSINESS WIRE)--Vision Medicines announces largest co-funding agreement to date with Foundation Fighting Blindness for Stargardt disease program. Stargardt is an orphan disease that leads to legal blindness.

Mon, 2015-11-09 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Warp Drive Bio Announces Breakthrough in the Ability to Target the Previously Undruggable Oncogene RAS

Mon, 2015-11-09 09:00

AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (Nasdaq:MIRN), a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics, today announced the presentation of interim results from its...

Mon, 2015-11-09 09:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, today announced consolidated financial results for the third quarter 2015 and highlighted recent progress in its advancing...

Mon, 2015-11-09 09:00

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences: Jefferies Autumn 2015 Global Healthcare Conference on...

Mon, 2015-11-09 09:00

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the third quarter ended September 30, 2015, and...

Mon, 2015-11-09 09:00

SEOUL, South Korea--(BUSINESS WIRE)--Hanmi Pharmaceuticals entered into an exclusive license, agreement with Janssen Pharmaceuticals for the development and commercialization of oxyntomodulin-based therapies including Hanmi's HM12525A.

Mon, 2015-11-09 09:00

TEL AVIV, Israel--(BUSINESS WIRE)--BioLineRx Ltd. announced that it will release its unaudited financial results for the third quarter ended September 30, 2015 on Monday, November 16, 2015, before the U.S. markets open.

Mon, 2015-11-09 08:00

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD today announced it has appointed Yasumasa Kurioka as general manager of PPD-SNBL, the joint venture formed between PPD and Shin Nippon Biomedical Laboratories Ltd.

Mon, 2015-11-09 08:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, today reported business highlights and operating and financial results for the...

Mon, 2015-11-09 08:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today reported financial results for the third quarter ended September 30, 2015 and provided a business update. “We completed partnerships for two of AVEO’s lead programs in the third...

Mon, 2015-11-09 08:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced that Tuan Ha-Ngoc, after 13 years of service and leadership at AVEO, has stepped down as Chairman and a Director of the Company’s board of directors, effective...

Mon, 2015-11-09 04:00

PARIS--(BUSINESS WIRE)--Lysogene, a leading, clinical-stage biotechnology company, makes two senior appointments to its financial team.

Mon, 2015-11-09 04:00

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Onxeo Reports Initial Results of Phase 1 Trial Evaluating Belinostat in Combination with CHOP in Peripheral T-cell Lymphoma (PTCL)

Sun, 2015-11-08 22:00

HONG KONG--(BUSINESS WIRE)--New technology to help reduce stress and pressure on shoulders when carrying a loaded bag

Sun, 2015-11-08 17:00

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX) (“Ignyta”), a precision oncology biotechnology company, today announced the exclusive license of worldwide rights relating to Eli Lilly and Company’s taladegib oncology development program...

Sun, 2015-11-08 14:00

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced that interim results from the company’s ongoing Phase 1 clinical trial of RXDX-105, the company’s orally-available, small...